All Biotech News

List of articles in category All Biotech News
Title	Published Date
RedHill Biopharma Provides Progress Update on RHB-104 Phase III Crohn’s Disease Program and Introduces Option for Early Stop for Success in Q2/2017	10/06/2016
Orchard Therapeutics Announces the Opening of US Operations in Foster City, California	10/06/2016
RedHill Biopharma Announces Initiation of Phase II Study with YELIVA™ in Hepatocellular Carcinoma at the Medical University of South Carolina	10/05/2016
Vector Vitale Announces New Paradigm in Medicine	10/05/2016
Karus Therapeutics Announces First Lymphoma Patients Dosed with KA2237 in Clinical Study at the MD Anderson Cancer Center	10/05/2016
Nuevolution Announces Strategic Collaboration with Amgen in Oncology and Neuroscience	10/04/2016
Argint International Voted as Top10 CRO	10/04/2016
Sartorius Stedim Biotech Launches Two Single-Use Sartocon® Loop Assemblies with Integrated Polyethersulfone (PESU) Membrane	09/30/2016
Dutch Mellon Medical Unveils Major Innovation in Surgical Suture Technology: Single-Handed Suturing Using The Switch®	09/30/2016
Quantapore Inc. Closes Series C Financing Round	09/27/2016
Shuwen Biotech's Clinical Lab Receives Accreditation from College of American Pathologists	09/23/2016
Nuevolution: Oral Presentation of Preclinical and Preliminary Toxicology Data on its BET BD1 Program at Discovery on Target 2016	09/22/2016
Orchard Therapeutics Announces Presentations from UCL/GOSH and UCLA Academic Collaborators on Clinical Data in ADA-SCID Using Ex-Vivo Lentiviral Gene Therapy at September 2016 ESID and ESGCT Congresses	09/21/2016
FierceBiotech Names Orchard Therapeutics Limited as One of Its “Fierce 15” Biotech Companies of 2016	09/21/2016
RedHill Biopharma and IntelGenx Announce RIZAPORT® Commercialization Term Sheet with Pharmatronic Co. for Korea	09/21/2016
TVM Life Science Ventures VII Announces Investment in AurKa Pharma Inc.	09/19/2016
osteomiR™: Worldwide First miRNA-based Test for Early Detection of Osteoporosis	09/19/2016
Nuevolution: Presentation of Preclinical Data on its BET BD1 Program at Discovery on Target 2016	09/16/2016
Sartorius Stedim Biotech Presents Sartocon® Slice 50 ECO	09/15/2016
RedHill Biopharma Announces Research Collaboration with Stanford University for YELIVA™	09/12/2016
RedHill Biopharma Announces Phase Ib/II Study with YELIVA™ Initiated for Multiple Myeloma at a Leading U.S. Academic Medical Center	09/08/2016
OrthoSera Receives CE Mark for hypACT™ Device to Regenerate Osteoarthritic Bone	09/07/2016
BioMed X Announces the Start of New Research Team on Oral Biofilm Disruption through Continued Collaboration with Johnson & Johnson Innovation	09/06/2016
AGC Acquires a Leading German Biopharmaceutical CMO	09/06/2016
Celonic and IBI-Lorenzini Announce a Strategic Collaboration on CHOvolution™, an Innovative Integrated Cell Line Development Platform	09/05/2016
Sartorius Stedim Biotech Presents the First Fully Integrated Upstream Platform	09/01/2016
Adherium Expands Its International Presence Announces Mr Thomas Lynch as Chairman and Dr Doug Wilson as Medical Director	09/01/2016
RedHill Biopharma Announces Approval of a European Patent Supporting RHB-104 for Multiple Sclerosis	08/29/2016
New England Journal of Medicine Publishes MINDACT Trial Results Proving the Clinical Utility of MammaPrint® in Assisting Physicians to Identify Early-Stage Breast Cancer Patients who can Safely Forgo Chemotherapy	08/24/2016
AYOXXA and Märzhäuser Introduce a Benchtop Device for Protein Multiplex Analysis	08/22/2016

Page 44 of 87